Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

NCT03473132 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulation
Anticoagulation Reversal

Interventions

DRUG: four factor prothrombin complex concentrate

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]